Russo et al., 2003 - Google Patents
Neuropsychological investigation into the carcinoid syndromeRusso et al., 2003
View PDF- Document ID
- 9181337980679581727
- Author
- Russo S
- Nielen M
- Boon J
- Kema I
- Willemse P
- De Vries E
- Korf J
- Den Boer J
- Publication year
- Publication venue
- Psychopharmacology
External Links
Snippet
Rationale In patients suffering from metastatic carcinoid tumors, chronic disturbances of serotonergic metabolism are frequently present. Serotonin is supposed to influence a range of cognitive functions. Objectives The present study evaluated the cognitive performance of …
- 230000003557 neuropsychological 0 title abstract description 9
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Łucka et al. | Orthorexia nervosa-a separate clinical entity, a part of eating disorder spectrum or another manifestation of obsessive-compulsive disorder | |
| Ma et al. | Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial | |
| Erkinjuntti | Cerebrovascular dementia: pathophysiology, diagnosis and treatment | |
| Angelopoulou et al. | APOE genotype and Alzheimer’s disease: the influence of lifestyle and environmental factors | |
| Turner et al. | Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder | |
| Sublette et al. | Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder | |
| Vine et al. | Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration | |
| Fratiglioni et al. | Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project | |
| Lavebratt et al. | The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression | |
| Rivas et al. | The Eating Attitudes Test (EAT-26): reliability and validity in Spanish female samples | |
| Nigg et al. | Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control | |
| Prins et al. | Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study | |
| Solon et al. | Associations between cognitive function, blood lead concentration, and nutrition among children in the central Philippines | |
| Caselli et al. | Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes | |
| Oades | Role of the serotonin system in ADHD: treatment implications | |
| Żarnowska et al. | Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy | |
| Dlugaj et al. | Anemia and mild cognitive impairment in the German general population | |
| Silani et al. | The diagnosis of Amyotrophic lateral sclerosis in 2010 | |
| Cordero et al. | Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma | |
| Russo et al. | Neuropsychological investigation into the carcinoid syndrome | |
| Wang et al. | Kidney function and dementia risk in community-dwelling older adults: the Shanghai Aging Study | |
| JP2022524850A (en) | Methods and Compositions for Diagnosing Depression | |
| Chen et al. | Acute phase serum leptin, adiponectin, interleukin-6, and visfatin are altered in Chinese children with febrile seizures: a cross-sectional study | |
| Zhou et al. | Prevalence and clinical-demographic correlates of hyperhomocysteinemia in inpatients with bipolar disorder in a Han Chinese population | |
| Jiang et al. | Nitrous oxide‐related neurological disorders: Clinical, laboratory, neuroimaging, and electrophysiological findings |